norethisterone 5mg tablets
de pharmaceuticals - norethisterone - oral tablet - 5mg
norethisterone 5mg tablets
kent pharma (uk) ltd - norethisterone - oral tablet - 5mg
norethisterone tablets 5mg
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - norethisterone - tablet - norethisterone 5 mg - sex hormones and modulators of the genital system
norethisterone 5mg tablets
wockhardt uk limited - norethisterone - tablet - norethisterone 5 mg - sex hormones and modulators of the genital system
dub-sterone tablet
dawa limited p.o box 16633-00620 nairobi, kenya - norethisterone acetate - tablet - norethisterone acetate equiv. norethisterone 5mg - hormonal contraceptives: progestogens for
primolut n 5mg tablets
bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - norethisterone - tablet - norethisterone 5 mg - sex hormones and modulators of the genital system
primolut n
bayer plc - norethisterone - tablet - norethisterone 5 mg - sex hormones and modulators of the genital system
trisequens estradiol tablets and norethisterone acetate plus estradiol tablets dial dispenser pack
novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 2.07 mg (equivalent: estradiol, qty 2 mg); norethisterone acetate, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hyprolose; purified talc; magnesium stearate; hypromellose; triacetin - short term symptomatic treatment of oestrogen deficiency associated with natural or artificial menopause (see dosage and administration and clinical trials).
kliogest estradiol 2mg and norethisterone acetate 1mg tablet dial dispenser pack
novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 2.07 mg (equivalent: estradiol, qty 2 mg); norethisterone acetate, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hyprolose; purified talc; magnesium stearate; hypromellose; triacetin - short term symptomatic treatment of postmenopausal oestrogen deficiency (see dosage and administration and clinical trials). for the prevention of postmenopausal bone mineral density loss. when prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profile of kliogest should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing. see precautions and dosage and administration. kliogest is for use in postmenopausal women with an intact uterus. in perimenopausal women treated with kliogest the incidence of vaginal bleeding is unacceptably high and therefore therapy should not be initiated sooner than one year after the last menstrual period.
noriday 28 day norethisterone 350 microgram tablet blister pack
pfizer australia pty ltd - norethisterone, quantity: 350 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; maize starch - indications as at 9 march 2003 : noriday is an oral contraceptive for women who will not, or cannot tolerate other oral contraceptives or intrauterine devices.